Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2003
09/17/2003EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
09/17/2003EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343492A2 Treatment of mucositis
09/17/2003EP1343490A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof
09/17/2003EP1343370A2 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
09/17/2003EP1282622B1 Crf receptor antagonists and methods relating thereto
09/17/2003EP1230260B1 Hcv ns3 protease inhibitors
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1192163B1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1140013B1 Foaming antacid suspension tablets
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003EP1095021B1 Quinoline derivatives
09/17/2003EP1091763B1 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0977737B1 Crf antagonistic quino- and quinazolines
09/17/2003EP0910566B1 Heterocyclic compounds and their preparation and use
09/17/2003EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity
09/17/2003EP0768089B1 Hot water extract of Cordyceps sinensis
09/17/2003EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443197A Acid-modified arabinogalactan protein composition
09/17/2003CN1443191A Methods and compositions for treating hepatitis c virus
09/17/2003CN1443190A Matrix metalloproteinase inhibitors
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443178A (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphtyl] -4-morpholibenzamide
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443085A Method for locating compounds which are suitable for treatment and/or prophylaxis of obesity
09/17/2003CN1443072A Compositions containing ascorbic acid phosphoric acid esters
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/17/2003CN1442430A AsLc-IFN fusion protein and its preparation
09/17/2003CN1442192A Quick acting stone resolving pill
09/17/2003CN1442190A Chinese medicine possessing kidney supplementing brain fortifying, statis transforming and vessel freeing actions
09/17/2003CN1442187A Chinese medicinal formula for treating chronic non specific ulcer colonitis
09/17/2003CN1442181A Medicine for treating chronic hepatitis
09/17/2003CN1442174A Chinese medicinal preparation for treating gallstone and its preparation method
09/17/2003CN1442169A Granula formulated medicine for freeing yang and antifatigue and its preparation method
09/17/2003CN1442168A Chinese medicine for supplementing kidney and fortifying spleen
09/17/2003CN1442164A Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method
09/17/2003CN1442155A Lulusu synthetic medicinal liquid
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1442093A Reyihan juice and its preparation method
09/17/2003CN1121387C Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
09/17/2003CN1121237C Health care products for regulating immunological function and delaying senility
09/17/2003CN1121225C Hepatitis treating medicine
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620845 For therapy and prophylaxis of neurological diseases
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/16/2003CA2261271C Dihydrodibenzo[b,e]oxazepine derivatives and pharmaceutical composition containing the same
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2172493C Use of angiotensin iii and analogs thereof in tissue repair
09/16/2003CA2107219C S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
09/16/2003CA2099898C Antibacterial antiplaque oral composition
09/16/2003CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
09/12/2003WO2003074514A1 Alkylammonium salts of omeprazole and esomeprazole
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074128A2 Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074071A1 Remedies for liver diseases, hyperlipemia and diabetes
09/12/2003WO2003074061A1 Electrolyte purgative
09/12/2003WO2003074040A1 Compositions for ameliorating fecal properties
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003045942A3 Chemokine receptor antagonists and methods of use thereof
09/12/2003WO2003041684A3 Injectable depot compositions and uses thereof
09/12/2003WO2003039260A3 Probiotic compositions
09/12/2003WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2003033027A3 Dendrimers for use in targeted delivery
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2001095785A3 Modulation of immune response and methods based thereon
09/12/2003CA2841310A1 Electrolyte purgative
09/12/2003CA2478135A1 Electrolyte purgative
09/12/2003CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
1 ... 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 ... 1258